샘플 요청 목록

 카트 문의
시장보고서
상품코드
1869841

세포 선별 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cell Sorting Market Size, Share & Trends Analysis Report By Product (Cell Sorters, Reagents & Consumables), By Technology, By Application (Research, Clinical), By End Use, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포 선별 시장 요약

세계의 세포 선별 시장 규모는 2024년에 2억 6,110만 달러로 평가되었고, 2033년까지 5억 6,910만 달러에 이를 것으로 예측됩니다.

2025년부터 2033년까지 연평균 복합 성장률(CAGR) 9.19%를 나타낼 전망입니다. 이 업계에서는 고속 분획이나 고도의 검출 능력 등 혁신 기술에 의해 정밀도와 효율이 향상되어 현저한 진보가 보이고 있습니다.

기술 혁신

기술적 진보로 세포 선별 시장은 현저하게 성장했습니다. 자동화, 소프트웨어 통합, 장치 감도의 향상으로 분취 결과의 신뢰성이 더욱 향상되어, 이러한 기술을 보다 다양한 연구실이나 임상 현장에서 이용 가능하게 되었습니다. 이에 따라 치료 및 조사 용도의 채용률이 상승하여 시장 확대를 촉진하고 있습니다. 이러한 발전으로 세포 선별 도구는 조사 및 임상 응용을 포함한 다양한 분야에서 필수적이었습니다. 특히 형광 활성화 세포 선별(FACS)은 세포 특성의 신속하고 정량적인 측정을 가능하게 하기 때문에 이질적인 세포 집단을 분취하는데 있어서 필수적인 툴로서 시장의 성장에 크게 공헌하고 있습니다.

게다가, 단백질체학, 유전체학, 고처리량 스크리닝 플랫폼과의 통합은 세포 선별 기술 시장 가능성과 유용성을 크게 확대했습니다. 이러한 기술의 융합이 학술·임상·산업 유저에게 가져오는 새로운 기회에 의해 세계의 세포 선별 시장은 지속적인 수요를 경험하고 있습니다.

자주 묻는 질문

  • 세포 선별 시장의 현재 규모와 미래 예측은 어떻게 되나요?
  • 세포 선별 시장의 기술 혁신은 어떤 영향을 미치고 있나요?
  • 형광 활성화 세포 선별(FACS)의 중요성은 무엇인가요?
  • 세포 선별 기술의 융합이 가져오는 기회는 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 보조 시장 전망
  • 시장 동향과 전망
  • 시장 역학
    • 시장 성장 촉진요인의 영향 분석
    • 시장 성장 억제요인의 영향 분석
  • 비즈니스 환경 분석
    • PESTLE 분석
    • Porter's Five Forces 분석

제4장 제품별 비즈니스 분석

  • 제품 부문 대시보드
  • 세계의 세포 선별 시장 제품 변동 분석
  • 세계의 세포 선별 시장 규모와 동향 분석(제품별, 2021-2033년)
  • 세포 선별 장치
  • 시약 및 소모품
  • 서비스

제5장 기술별 비즈니스 분석

  • 기술 부문 대시보드
  • 세계 세포 선별 시장 기술 변동 분석
  • 세계의 세포 선별 시장 규모와 동향 분석(기술별, 2021-2033년)
  • 형광 기반 액적 세포 선별
  • 자기 활성화 세포 선별
  • MEMS-마이크로유체학

제6장 용도별 비즈니스 분석

  • 용도 부문 대시보드
  • 세계의 세포 선별 시장의 용도, 변동 분석
  • 세계의 세포 선별 시장 규모와 동향 분석(용도별, 2021-2033년)
  • 연구 용도
  • 임상 용도

제7장 최종 용도별 비즈니스 분석

  • 최종 용도 부문 대시보드
  • 세계의 세포 선별 시장의 최종 용도, 변동 분석
  • 세계의 세포 선별 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
  • 연구 기관
  • 의과대학 및 학술기관
  • 제약 및 생명 공학 기업
  • 병원 및 임상 실험실

제8장 세포 선별 시장 : 제품, 기술, 용도, 최종 용도별 지역 추정 및 동향 분석

  • 지역 대시보드
  • 시장 규모와 예측 및 동향 분석(2021-2033년)
  • 북미
    • 북미의 세포 선별 시장(2021-2033년)
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 유럽의 세포 선별 시장(2021-2033년)
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 아시아태평양의 세포 선별 시장(2021-2033년)
    • 일본
    • 중국
    • 인도
    • 싱가포르
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 라틴아메리카의 세포 선별 시장(2021-2033년)
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • MEA의 세포 선별 시장(2021-2033년)
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제9장 경쟁 구도

  • 기업 분류
  • 전략 매핑
  • 기업시장 포지셔닝 분석(2024년)
  • 기업 프로파일
    • BD
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Sony Group Corporation
    • Miltenyi Biotec
    • On-chip Biotechnologies Co., Ltd.
    • Cytonome/ST, LLC
    • Union Biometrica, Inc.
    • Thermo Fisher Scientific Inc.
    • uFluidix
KTH 25.12.11

Cell Sorting Market Summary

The global cell sorting market size was estimated at USD 261.1 million in 2024 and is projected to reach USD 569.1 million by 2033, growing at a CAGR of 9.19% from 2025 to 2033. The industry has witnessed significant advancements, driven by innovations such as high-speed sorting and advanced detection capabilities, which enhance precision and efficiency.

Technological Innovations

The market for cell sorting has grown significantly due to technological advancements. The reliability of sorting results has been further improved by automation, software integration, and instrument sensitivity advancements, opening these technologies to a greater variety of labs and clinical settings. Because of this, adoption rates have increased for therapeutic and research applications, which has fueled market expansion. These advancements have made cell sorting tools essential in various fields, including research and clinical applications. Fluorescence-Activated Cell Sorting (FACS), in particular, is a significant contributor to the market's growth due to its ability to provide quick and quantitative measurements of cell properties, making it an essential tool for sorting heterogeneous cell populations.

Moreover, its integration with proteomics, genomics, and high-throughput screening platforms has greatly expanded cell sorting's market potential and usefulness. The global cell sorting market is experiencing sustained demand due to the new opportunities this convergence of technologies brings to academic, clinical, and industrial users.

Global Cell Sorting Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell sorting market on the basis of product, technology, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Sorters
  • Reagents and Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Fluorescence-based Droplet Cell Sorting
    • Jet-in-air Cell Sorting
    • Cuvette-based Cell Sorting
  • Magnetic-activated Cell Sorting
  • MEMS - Microfluidics
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research Applications
    • Immunology & Cancer Research
    • Stem Cell Research
    • Drug Discovery
    • Other Research Applications
  • Clinical Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Research Institutions
  • Medical Schools and Academic Institutions
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinical Testing Laboratories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Technology innovations
      • 3.3.1.2. Increasing clinical applications
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. High cost of instruments and consumables
      • 3.3.2.2. Technical complexity and requirement for skilled personnel
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Cell Sorting Market Product, Movement Analysis
  • 4.3. Global Cell Sorting Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Cell Sorters
    • 4.4.1. Global cell sorters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reagents and Consumables
    • 4.5.1. Global reagents and consumables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Global services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global Cell Sorting Market Technology, Movement Analysis
  • 5.3. Global Cell Sorting Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Fluorescence-based Droplet Cell Sorting
    • 5.4.1. Global fluorescence-based droplet cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.1. Jet-in-air Cell Sorting
        • 5.4.1.1.1. Global jet-in-air cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.2. Cuvette-based Cell Sorting
        • 5.4.1.2.1. Global cuvette-based cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Magnetic-activated Cell Sorting
    • 5.5.1. Global magnetic-activated cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. MEMS - Microfluidics
    • 5.6.1. Global MEMS - microfluidics cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Cell Sorting Market Application, Movement Analysis
  • 6.3. Global Cell Sorting Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Research Applications
    • 6.4.1. Global research applications cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
      • 6.4.1.1. Immunology & Cancer Research
        • 6.4.1.1.1. Global immunology & cancer research market estimates and forecasts, 2021 - 2033 (USD Million)
      • 6.4.1.2. Stem Cell Research
        • 6.4.1.2.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD Million)
      • 6.4.1.3. Drug Discovery
        • 6.4.1.3.1. Global drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
      • 6.4.1.4. Other Research Applications
        • 6.4.1.4.1. Global other research applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Clinical Applications
    • 6.5.1. Global clinical applications market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Cell Sorting Market End Use, Movement Analysis
  • 7.3. Global Cell Sorting Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Research Institutions
    • 7.4.1. Global research institutions companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Medical Schools and Academic Institutions
    • 7.5.1. Global medical schools and academic institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Pharmaceutical and Biotechnology Companies
    • 7.6.1. Global pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Hospitals and Clinical Testing Laboratories
    • 7.7.1. Global hospitals and clinical testing laboratories market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cell Sorting Market: Regional Estimates and Trend Analysis, by Product, Technology, Application, & End use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America cell sorting market, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. U.S. cell sorting market, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Canada cell sorting market, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Mexcio cell sorting market, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. UK cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Germany cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. France cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Italy cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Spain cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Denmark cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Sweden cell sorting market, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Norway cell sorting market, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Japan cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. China cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. India cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.5. Singapore
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Singapore cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Regulatory Framework
      • 8.5.6.5. Australia cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Regulatory Framework
      • 8.5.7.5. Thailand cell sorting market, 2021 - 2033 (USD Million)
    • 8.5.8. South Korea
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Regulatory Framework
      • 8.5.8.5. South Korea cell sorting market, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America cell sorting market, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Brazil cell sorting market, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Argentina cell sorting market, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA cell sorting market, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Regulatory Framework
      • 8.7.2.5. South Africa cell sorting market, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Regulatory Framework
      • 8.7.3.5. Saudi Arabia cell sorting market, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Target Disease Prevalence
      • 8.7.4.3. Competitive Scenario
      • 8.7.4.4. Regulatory Framework
      • 8.7.4.5. UAE cell sorting market, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Target Disease Prevalence
      • 8.7.5.3. Competitive Scenario
      • 8.7.5.4. Regulatory Framework
      • 8.7.5.5. Kuwait cell sorting market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. BD
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Bio-Rad Laboratories, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Danaher Corporation
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Sony Group Corporation
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Miltenyi Biotec
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. On-chip Biotechnologies Co., Ltd.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Cytonome/ST, LLC
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Union Biometrica, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Thermo Fisher Scientific Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. uFluidix
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제